Levodopa-induced ocular dyskinesia in Parkinson's disease
- PMID: 17880568
- DOI: 10.1111/j.1468-1331.2007.01919.x
Levodopa-induced ocular dyskinesia in Parkinson's disease
Abstract
Levodopa (LD)-induced dyskinesia (LID), one of the most common motor complications in advanced Parkinson's disease (PD), involve mostly the limbs, trunk and head, but unusual locations have been reported including respiratory muscles, the face and the eyes. The aim of this study was to further investigate the frequency and characteristics of LD-related abnormal involuntary eye movements (AIEMs) in PD. Thirty-two patients with advanced PD and various motor complications were evaluated and videotaped in an ON and OFF state. We found AIEMs in five patients (16%) which were present exclusively during the ON state and which completely disappeared when OFF. They consisted of repeated, stereotyped upward and/or sideways gaze deviation movements, sometimes phasic, brief and jerky, sometimes tonic and sustained for several seconds. The main direction of gaze deviation was toward the side more affected by parkinsonism. AIEMs typically paralleled limb and trunk LID and were modulated by the same facilitation and inhibitory maneuvers. We concluded that AIEMs are not uncommon in advanced PD and represent a particular topography of LID, hence the term 'ocular dyskinesia' to designate these AIEMs that seem to have a specific pattern in PD as compared with other forms of parkinsonism.
Similar articles
-
Conjugate eye deviations as dyskinesias induced by levodopa in Parkinson's disease.Mov Disord. 1998 Jul;13(4):731-4. doi: 10.1002/mds.870130421. Mov Disord. 1998. PMID: 9686783
-
Levodopa-induced ocular dyskinesias in Parkinson's disease.Mov Disord. 2002 Jan;17(1):186-7. doi: 10.1002/mds.10017. Mov Disord. 2002. PMID: 11835460
-
The relationship between the phenotype of Parkinson's disease and levodopa-induced dyskinesia.Neurosci Lett. 2013 Nov 27;556:109-12. doi: 10.1016/j.neulet.2013.10.018. Epub 2013 Oct 14. Neurosci Lett. 2013. PMID: 24135335
-
Levodopa-induced dyskinesia in Parkinson's disease.J Neural Transm (Vienna). 2005 Mar;112(3):359-91. doi: 10.1007/s00702-004-0251-7. Epub 2004 Dec 22. J Neural Transm (Vienna). 2005. PMID: 15614429 Review.
-
Levodopa, motor fluctuations and dyskinesia in Parkinson's disease.Expert Opin Pharmacother. 2006 Sep;7(13):1715-30. doi: 10.1517/14656566.7.13.1715. Expert Opin Pharmacother. 2006. PMID: 16925499 Review.
Cited by
-
Case report: Blepharospasm in peak-dose dyskinesia may benefit from amantadine in Parkinson's disease.Front Neurol. 2022 Sep 30;13:961758. doi: 10.3389/fneur.2022.961758. eCollection 2022. Front Neurol. 2022. PMID: 36247788 Free PMC article.
-
Levodopa-Induced Ocular Dyskinesia in an Early-Onset Parkinson Disease Patient With GBA Mutation.Clin Neuropharmacol. 2021 Nov-Dec 01;44(6):201-204. doi: 10.1097/WNF.0000000000000484. Clin Neuropharmacol. 2021. PMID: 34654015 Free PMC article.
-
A video-atlas of levodopa-induced dyskinesia in Parkinson's disease: terminology matters.Neurol Sci. 2024 Apr;45(4):1389-1397. doi: 10.1007/s10072-023-07209-6. Epub 2023 Nov 21. Neurol Sci. 2024. PMID: 37987930 Review.
-
Ophthalmate is a new regulator of motor functions via CaSR: implications for movement disorders.Brain. 2024 Oct 3;147(10):3379-3394. doi: 10.1093/brain/awae097. Brain. 2024. PMID: 38537648 Free PMC article.
-
Oculogyric Crisis Phenotype of Levodopa-Induced Ocular Dyskinesia.Mov Disord Clin Pract. 2022 Feb 10;9(3):390-393. doi: 10.1002/mdc3.13416. eCollection 2022 Apr. Mov Disord Clin Pract. 2022. PMID: 36989007 Free PMC article. No abstract available.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous